Metropolis Healthcare Limited (METROPOLIS) - Total Liabilities

Latest as of September 2025: Rs5.49 Billion INR ≈ $59.42 Million USD

Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has total liabilities worth Rs5.49 Billion INR (≈ $59.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Metropolis Healthcare Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Metropolis Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. See Metropolis Healthcare Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Metropolis Healthcare Limited Competitors by Total Liabilities

The table below lists competitors of Metropolis Healthcare Limited ranked by their total liabilities.

Company Country Total Liabilities
Hubtown Limited
NSE:HUBTOWN
India Rs31.54 Billion
Neuberger Berman IMF Inc
NYSE MKT:NBH
USA $231.69 Million
Pum-Tech Korea Co. Ltd
KQ:251970
Korea ₩107.05 Billion
Value Line Inc
NASDAQ:VALU
USA $43.20 Million
Jiangxi Hengda Hi-Tech Co Ltd
SHE:002591
China CN¥218.72 Million
Keyfield International Berhad
KLSE:5321
Malaysia RM395.05 Million
TRX Gold Corporation
TO:TRX
Canada CA$45.94 Million
Orient Cement Limited
NSE:ORIENTCEM
India Rs9.01 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Metropolis Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Metropolis Healthcare Limited worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.20 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.38 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Metropolis Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual total liabilities of Metropolis Healthcare Limited from 2014 to 2025.

Year Total Liabilities Change
2025-03-31 Rs5.33 Billion
≈ $57.61 Million
+16.87%
2024-03-31 Rs4.56 Billion
≈ $49.29 Million
-10.79%
2023-03-31 Rs5.11 Billion
≈ $55.25 Million
-20.44%
2022-03-31 Rs6.42 Billion
≈ $69.44 Million
+116.68%
2021-03-31 Rs2.96 Billion
≈ $32.05 Million
+30.51%
2020-03-31 Rs2.27 Billion
≈ $24.56 Million
+71.16%
2019-03-31 Rs1.33 Billion
≈ $14.35 Million
+31.09%
2018-03-31 Rs1.01 Billion
≈ $10.95 Million
-40.82%
2017-03-31 Rs1.71 Billion
≈ $18.49 Million
+67.59%
2016-03-31 Rs1.02 Billion
≈ $11.03 Million
+28.83%
2015-03-31 Rs791.99 Million
≈ $8.57 Million
+5.94%
2014-03-31 Rs747.56 Million
≈ $8.08 Million
--

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research
Market Cap
$304.09 Million
Rs28.12 Billion INR
Market Cap Rank
#14844 Global
#741 in India
Share Price
Rs542.50
Change (1 day)
-0.57%
52-Week Range
Rs421.75 - Rs2236.70
All Time High
Rs3431.71
About

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more